MedPath

Correlating the Measure of Retinal Vascular Density Through Angio-OCT with Calcium Score

Not Applicable
Completed
Conditions
Vascular Diseases
Cardiovascular Abnormalities
Retinal Vascular
Interventions
Other: Ophthalmologic consultation
Registration Number
NCT05624255
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

Recent case-control studies have proven that the retinal vascularization mirrors the cardiac vascularization: more the coronary network is altered, more the density of retinal vessels is reduced. No studies have yet been realised in primary prevention. This study aims to demonstrate a link between the density of the retinal vascularization and the calcium score, which is currently the gold standard for the classification of cardiovascular risk in primary prevention. Thus, a simple image of the retinal vascularization could predict the cardiovascular risk of a patient. OCT angiography would become a major aid in the classification of cardiovascular risk in asymptomatic patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
101
Inclusion Criteria
  • Patients eligible for a calcium score as part of their standard treatment and volunteers for an ophthalmologic consultation
Exclusion Criteria
  • Pregnant women

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ophthalmology consultationOphthalmologic consultationPatients eligible to calcium score will be offered an ophthalmologic consultation including Angio-Optical Coherence Tomography \[OCT\]
Primary Outcome Measures
NameTimeMethod
Correlation between retinal vascular density and calcium scoreDay 1

Comparison between values of calcium score and presence of vascular abnormalities in retina.

Calcium is scored as follows:

* Coronary Artery Calcium \[CAC\] = 0 : very low risk

* CAC = \[1-100\[ : low risk

* CAC = \[100-400\[ : moderate risque

* CAC = \[400-1000\[ : high risk

* CAC = \> 1000 : very high risk

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU de Besançon

🇫🇷

Besançon, France

© Copyright 2025. All Rights Reserved by MedPath